| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |